Carl W. Porter
- Biochemistry top 0.02%
- Amino Acid Enzymes and Metabolism 91
- Pharmacology top 0.2%
- Cannabis and Cannabinoid Research 22
- Molecular Biology top 0.5%
- Polyamine Metabolism and Applications 120
- Epigenetics and DNA Methylation 39
- Biochemical and Molecular Research 9
- Cancer-related gene regulation 7
- Genetics top 2%
- Biotechnology top 2%
- Cancer Research and Treatments 8
-
- Metabolism and Genetic Disorders 8
- Co-authors
- Raymond J. BergeronDebora L. KramerPaula DiegelmanSlavoljub VujcicPaul R. LibbyRalph J. BernackiB. GanisEric A. Barnard
- Partner nations
- United StatesFinlandSwitzerland
In The Last Decade
Carl W. Porter
166 papers receiving 7.3k citations
Peers
Comparison fields: 5 of 132
- Biochemistry 3.1k
- Pharmacology 1.9k
- Molecular Biology 6.3k
- Genetics 354
- Biotechnology 249
Countries citing papers authored by Carl W. Porter
This map shows the geographic impact of Carl W. Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl W. Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl W. Porter more than expected).
Fields of papers citing papers by Carl W. Porter
This network shows the impact of papers produced by Carl W. Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl W. Porter. The network helps show where Carl W. Porter may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Carl W. Porter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 24 | |
| 2 | 2006 | 314 | |
| 3 | 2004 | 42 | |
| 4 | 2002 | 17 | |
| 5 | Apoptotic signaling in polyamine analogue-treated SK-MEL-28 human melanoma cells. | 2001 | 88 |
| 6 | Spermidine/spermine n(1)-acetyltransferase catalyzes amantadine acetylation. | 2001 | 17 |
| 7 | 2000 | 110 | |
| 8 | Lysosomal sequestration of polyamine analogues in Chinese hamster ovary cells resistant to the S-adenosylmethionine decarboxylase inhibitor, CGP-48664. | 1998 | 11 |
| 9 | Effects of novel spermine analogues on cell cycle progression and apoptosis in MALME-3M human melanoma cells. | 1997 | 47 |
| 10 | Sequence specific antisense oligonucleotide analog interference with spermidine/spermine N1-acetyltransferase gene expression. | 1996 | 4 |
| 11 | Antitumor activity of N1,N11-bis(ethyl)norspermine against human melanoma xenografts and possible biochemical correlates of drug action. | 1993 | 67 |
| 12 | Differential effects of the spermine analog, N1, N12-bis(ethyl)-spermine, on polyamine metabolism and cell growth in human melanoma cell lines and melanocytes. | 1992 | 47 |
| 13 | Antitumor activity of N,N'-bis(ethyl)spermine homologues against human MALME-3 melanoma xenografts. | 1992 | 85 |
| 14 | 1992 | 33 | |
| 15 | Correlations between polyamine analogue-induced increases in spermidine/spermine N1-acetyltransferase activity, polyamine pool depletion, and growth inhibition in human melanoma cell lines. | 1991 | 184 |
| 16 | Major increases in spermidine/spermine-N1-acetyltransferase activity by spermine analogues and their relationship to polyamine depletion and growth inhibition in L1210 cells. | 1989 | 50 |
| 17 | 1987 | 47 | |
| 18 | Comparison of the biological effects of four irreversible inhibitors of ornithine decarboxylase in two murine lymphocytic leukemia cell lines. | 1986 | 40 |
| 19 | Comparative effects of methylglyoxal-bis(guanylhydrazone) (mgbg) on mitochondrial (mt) and nuclear (n) dna of mouse leukemia l1210 cells in culture. Abstr. | 1978 | 1 |
| 20 | Cell population kinetics of fast- and slow-growing transplantable tumors derived from spontaneous mammary tumors of the DBA/2 Ha-DD mouse. | 1978 | 18 |
About Carl W. Porter
Carl W. Porter is a scholar working on Biochemistry, Molecular Biology and Pharmacology, having authored 166 papers that have together received 7.7k indexed citations. Recurring topics across this work include Polyamine Metabolism and Applications (120 papers), Amino Acid Enzymes and Metabolism (91 papers), Epigenetics and DNA Methylation (39 papers), Cannabis and Cannabinoid Research (22 papers), Biochemical and Molecular Research (9 papers), Metabolism and Genetic Disorders (8 papers), Cancer Research and Treatments (8 papers) and Cancer-related gene regulation (7 papers). The work is most often cited by research in Biochemistry (3.1k citations), Pharmacology (1.9k citations) and Molecular Biology (6.3k citations). Carl W. Porter has collaborated with scholars based in United States, Finland and Switzerland. Frequent co-authors include Raymond J. Bergeron, Debora L. Kramer, Paula Diegelman, Slavoljub Vujcic, Paul R. Libby, Ralph J. Bernacki, B. Ganis, Eric A. Barnard, Thomas J. Dougherty and Peter J. Bugelski. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.